CS logo
small CS logo
Carolina Cardiology Cornerstone

High Point, North Carolina, United States

About Carolina Cardiology Cornerstone


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Carolina Cardiology Cornerstone


During the past decade, Carolina Cardiology Cornerstone conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
GLORIA-AF Registry Program - Second and Third Phases
2011-11-07
2020-01-10
Completed
37,235
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF
2018-06-15
2019-11-04
Completed
789
A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
2018-11-20
2021-04-22
Completed
2,002
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
2019-06-11
2025-07-26
Active, not recruiting
12,301
A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer
2019-09-16
2023-03-23
Withdrawn
0
Study of HEMAX PFS Versus EPREX/ ERYPO® in Predialysis Chronic Kidney Disease
2018-02-28
2022-01-30
Unknown status
120

Rows per page:

1–20 of 20

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Carolina Cardiology Cornerstone


According to Clinical.Site data, the most researched conditions in "Carolina Cardiology Cornerstone" are "Cardiovascular Disease" (2 trials), "Atrial Fibrillation" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Carolina Cardiology Cornerstone" in a lesser frequency.

Clinical Trials Intervention Types at Carolina Cardiology Cornerstone


Most popular intervention types in "Carolina Cardiology Cornerstone" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Carolina Cardiology Cornerstone


The vast majority of trials in "Carolina Cardiology Cornerstone" are 3 trials for "All" genders.

Clinical Trials Status at Carolina Cardiology Cornerstone


Currently, there are NaN active trials in "Carolina Cardiology Cornerstone". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Carolina Cardiology Cornerstone, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Carolina Cardiology Cornerstone, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status